 HIV Infections
"HIV Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Descriptor ID |
D015658
|
| MeSH Number(s) |
C02.782.815.616.400 C02.800.801.400 C20.673.480
|
| Concept/Terms |
HIV Infections- HIV Infections
- HIV Infection
- Infection, HIV
- Infections, HIV
- HTLV-III-LAV Infections
- HTLV III LAV Infections
- HTLV-III-LAV Infection
- Infection, HTLV-III-LAV
- Infections, HTLV-III-LAV
- T-Lymphotropic Virus Type III Infections, Human
- T Lymphotropic Virus Type III Infections, Human
- HTLV-III Infections
- HTLV III Infections
- HTLV-III Infection
- Infection, HTLV-III
- Infections, HTLV-III
HIV Coinfection- HIV Coinfection
- Coinfection, HIV
- Coinfections, HIV
- HIV Coinfections
|
Below are MeSH descriptors whose meaning is more general than "HIV Infections".
Below are MeSH descriptors whose meaning is more specific than "HIV Infections".
This graph shows the total number of publications written about "HIV Infections" by people in this website by year, and whether "HIV Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 6 | 0 | 6 | | 1997 | 2 | 2 | 4 | | 1998 | 16 | 3 | 19 | | 1999 | 16 | 4 | 20 | | 2000 | 24 | 3 | 27 | | 2001 | 19 | 2 | 21 | | 2002 | 20 | 7 | 27 | | 2003 | 15 | 11 | 26 | | 2004 | 42 | 9 | 51 | | 2005 | 35 | 6 | 41 | | 2006 | 39 | 3 | 42 | | 2007 | 45 | 9 | 54 | | 2008 | 42 | 4 | 46 | | 2009 | 46 | 7 | 53 | | 2010 | 46 | 15 | 61 | | 2011 | 75 | 10 | 85 | | 2012 | 53 | 13 | 66 | | 2013 | 78 | 13 | 91 | | 2014 | 103 | 11 | 114 | | 2015 | 77 | 10 | 87 | | 2016 | 101 | 11 | 112 | | 2017 | 98 | 13 | 111 | | 2018 | 108 | 14 | 122 | | 2019 | 116 | 14 | 130 | | 2020 | 110 | 6 | 116 | | 2021 | 146 | 6 | 152 | | 2022 | 135 | 3 | 138 | | 2023 | 106 | 1 | 107 | | 2024 | 104 | 6 | 110 | | 2025 | 81 | 12 | 93 | | 2026 | 64 | 3 | 67 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV Infections" by people in Profiles.
-
Wu Q, Karim S, Van MT, Enns B, Guerra-Alejos BC, Marshall BDL, Schackman BR, Del Rio C, Behrends CN, Enns E, Tookes HE, Rosen-Metsch L, Golden M, Strathdee SA, Mehta SH, Armstrong WS, Nosyk B, Zang X. Effect of COVID-19 on Late HIV Diagnosis Rates by Race/Ethnicity in Ending the HIV Epidemic Priority Jurisdictions in the United States. J Acquir Immune Defic Syndr. 2026 Aug 01; 101(8):803-811.
-
Kasirye R, Yang P, White JL, Tassiopoulos K, Granche J, Chauhan L, Nakabiito C, Fowler MG, Tobian AAR, Musoke P, Erlandson KM. Hospitalization Rates and Associated Factors Among Older Adults With HIV in the United States. J Acquir Immune Defic Syndr. 2026 Aug 01; 101(8):836-843.
-
Koethe JR, Lake JE, Kantor A, Smeaton L, Erlandson K, Moran L, Belaunzaran-Zamudio P, Landay A, Campo RE, Debroy P, Bennet JA, O'Halloran J, Han WM, Alli O, Leonard M, Gulick RM. A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391). Clin Infect Dis. 2026 Jul 23; 83(1):e81-e89.
-
Iriarte E, Erlandson KM. Interventions and opportunities to enhance aging among people with HIV: a focus on frailty, sarcopenia, and intrinsic capacity. Top Antivir Med. 2026 Jul 16; 34(3):554-560.
-
Ridolfi F, Amorim G, Haas DW, Arriaga M, Staats C, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Andrade BB, Sterling TR, Rolla VC, Benjamin A, Sant'Anna FM, Oliveira JG, Marin J, Rezende A, Carvalho AC, Rocha M, Nogueira B, Brito A, Spener R, Turner M. Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil. Mem Inst Oswaldo Cruz. 2026; 121:e250090.
-
Lee JS, Humes E, Haw NJL, Hogan B, Zheng C, Coburn S, Lesko CR, Lang R, Gill MJ, Horberg M, Silverberg MJ, Palella FJ, Delaney JA, Rebeiro PF, Sterling T, Rodriguez-Barradas M, Marconi VC, Yendewa GA, Klein MB, Moore R, Althoff KN. Harmonizing HIV-1 RNA laboratory measurements in a longitudinal cohort collaboration. Am J Epidemiol. 2026 Jul 08; 195(7):2055-2063.
-
Gonzalez H, Ridgeway K, Shorer EF, Dastgheyb R, Rajagopal R, Cao Y, Morack R, Hahm E, Weber KM, Rubin LH, French AL. Plasma suPAR and domain-specific cognitive performance in virologically suppressed women with HIV. J Neurovirol. 2026 Jul 08; 32(4).
-
Erlandson KM, Gustafson L, Johnson JE, Kulik GL, Khuu V, Chahal N, Walpert AR, Galdamez ME, Zorgno I, Foldyna B, Jarraya M, Reusch JE, Lee H, Grinspoon SK, Jankowski CM, Fourman LT. Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol. BMJ Open. 2026 Jul 08; 16(7):e120740.
-
Magidson JF, Hines AC, Majokweni SH, Tokwe L, Myers B, Du Toit S, Regenauer K, Andersen LS, Burnhams W, Orrell C, Murphy SM, Sibeko G, Triplett N, Ndwandwa E, Kotelo NN, Ma T, Safren S, Joska J. A Stepped Care, Peer-Delivered Intervention to Improve Substance Use and HIV Medication Adherence in Primary Care in South Africa (Project Khanya): Protocol for a Hybrid Type 2 Effectiveness-Implementation Randomized Controlled Trial. JMIR Res Protoc. 2026 Jul 02; 15:e94153.
-
Oliveira VHF, Dos Santos AP, Kulik GL, Horvat Davey C, Iriarte E, Jones R, Wilson MP, Khuu V, Ghosh D, Mawhinney S, Jankowski CM, Cook P, Erlandson KM, Webel AR. Frailty phenotype transitions and functional improvements during a supervised exercise trial in older people with HIV: results from the HEALTH Trial. Age Ageing. 2026 Jul 02; 55(7).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|